Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy

Diabetes

Volumn 55, Issue 11, 2006, Pages 2993-3003

  Schmid, Holger ^a   Boucherot, Anissa ^a,b   Yasuda, Yoshinari ^a   Henger, Anna ^a,f   Brunner, Bodo ^b   Eichinger, Felix ^a,f   Nitsche, Almut ^b   Kiss, Eva ^c   Bleich, Markus ^d   Gröne, Hermann Josef ^c   Nelson, Peter J ^a   Schlöndorff, Detlef ^a   Cohen, Clemens D ^a   Kretzler, Matthias ^a,e,f  

^a UNIVERSITY OF MUNICH   (Germany)

^b SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY OF MICHIGAN   (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; MALE; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS;

BIOPSY; CADAVER; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; KIDNEY; LIVING DONORS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; RNA, MESSENGER; TISSUE DONORS; TRANSCRIPTION, GENETIC;

EID: 33845526226     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0477     Document Type: Article

References (30)

1. O'Connor AS, Schelling JR: Diabetes and the kidney. Am J Kidney Dis 46:766-773, 2005
2. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 56:1627-1637, 1999
3. Bohle A, Wehrmann M, Bogenschutz O, Batz C, Muller CA, Muller GA: The pathogenesis of chronic renal failure in diabetic nephropathy: investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 187:251-259, 1991
4. Galkina E, Ley K: Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol 17:368-377, 2006
5. Navarro JF, Mora C: Role of inflammation in diabetic complications. Nephrol Dial Transplant 20:2601-2604, 2005
6. Mezzano S, Aros C, Droguett A, Burgos ME, Ardiles L, Flores C, Schneider H, Ruiz-Ortega M, Egido J: NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant 19:2505-2512, 2004
7. Sakai N, Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K, Kokubo S, Kobayashi M, Hara A, Yamahana J, Okumura T, Takasawa K, Takeda S, Yoshimura M, Kida H, Yokoyama H: Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis 45:54-65, 2005
8. Cohen CD, Frach K, Schlondorff D, Kretzler M: Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application Kidney Int 61:133-140, 2002
9. Phillips J, Eberwine JH: Antisense RNA amplification: a linear amplification method for analyzing the mRNA population from single living cells. Methods 10:283-288, 1996
10. Eisen MB, Spellman PT, Brown PO, Bolstein D: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:14863-14868, 1998
11. Frech K, Danescu-Mayer J, Werner T: A novel method to develop highly specific models for regulatory units detects a new LTR in GenBank which contains a functional promoter. J Mol Biol 270:674-687, 1997
12. Werner T: Cluster analysis and promoter modelling as bioinformatics tools for the identification of target genes from expression array data. Pharmacogenomics 2:25-36, 2001
13. Kim T, Yoon J, Cho H, Lee WB, Kim J, Song YH, Kim SN, Yoon JH, Kim-Ha J, Kim YJ: Downregulation of lipopolysaccharide response in Drosophila by negative crosstalk between the AP1 and NF-kappaB signaling modules. Nat Immunol 6:211-218, 2005
14. Johnson DR, Pober JS: HLA class I heavy-chain gene promoter elements mediating synergy between tumor necrosis factor and interferons. Mol Cell Biol 14:1322-1332, 1994
15. Karin M, Greten FR: NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759, 2005
16. Li Q, Verma IM: NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725-734, 2002
17. Yamamoto Y, Gaynor RB: Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr Mol Med 1:287-296, 2001
18. Cohen CD, Klingenhoff A, Boucherot A, Nitsche A, Henger A, Brunner B, Schmid H, Merkle M, Saleem MA, Koller KP, Werner T, Gröne HJ, Nelson PJ, Kretzler M: Comparative promoter analysis allows de novo identification of specialized cell junction associated proteins. Proc Natl Acad Sci U S A 103:5682-5687, 2006
19. Ohmori Y, Hamilton TA: The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J Immunol 154:5235-5244, 1995
20. Genin P, Algarte M, Roof P, Lin R, Hiscott J: Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J Immunol 164:5352-5361, 2000
21. Woods M, Wood EG, Bardswell SC, Bishop-Bailey D, Barker S, Wort SJ, Mitchell JA, Warner TD: Role for nuclear factor-kappaB and signal transducer and activator of transcription 1/interferon regulatory factor-1 in cytokine-induced endothelin-1 release in human vascular smooth muscle cells. Mol Pharmacol 64:923-931, 2003
22. Kirchhoff S, Wilhelm D, Angel P, Hauser H: NFkappaB activation is required for interferon regulatory factor-1-mediated interferon beta induction. Eur J Biochem 261:546-554, 1999
23. Kinugawa K, Shimizu T, Yao A, Kohmoto O, Serizawa T, Takahashi T: Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ Res 81:911-921, 1997
24. Neish AS, Read MA, Thanos D, Pine R, Maniatis T, Collins T: Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 15:2558-2569, 1995
25. Nakajima K, Tanaka Y, Nomiyama T, Ogihara T, Ikeda F, Kanno R, Iwashita N, Sakai K, Watada H, Onuma T, Kawamori R: RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects. Diabetes Care 26:892-898, 2003
26. Blanco S, Vaquero M, Gomez-Guerrero C, Lopez D, Egido J, Romero R: Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension. Am J Hypertens 18:557-565, 2005
27. Koga M, Otsuki M, Kubo M, Hashimoto J, Kasayama S: Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus. Diabet Med 15:661-667, 1998
28. Ina K, Kitamura H, Okeda T, Nagai K, Liu ZY, Matsuda M, Fujikura Y: Vascular cell adhesion molecule-1 expression in the renal interstitium of diabetic KKAy mice. Diabetes Res Clin Pract 44:1-8, 1999
29. Utimura R, Fujihara CK, Mattar AL, Malheiros DM, Noronha IL, Zatz R: Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 63:209-216, 2003
30. Yozai K, Shikata K, Sasaki M, Tone A, Ohga S, Usui H, Okada S, Wada J, Nagase R, Ogawa D, Shikata Y, Makino H: Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions. J Am Soc Nephrol 16:3326-3338, 2005